Arilvax PowderJect

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)992-995
Number of pages4
JournalCurrent Opinion in Investigational Drugs
Volume3
Issue number7
StatePublished - Jul 1 2002

Fingerprint

Viral Vaccines
Yellow Fever
Drug Industry
Clinical Trials

ASJC Scopus subject areas

  • Pharmacology

Cite this

Arilvax PowderJect. / Barrett, Alan.

In: Current Opinion in Investigational Drugs, Vol. 3, No. 7, 01.07.2002, p. 992-995.

Research output: Contribution to journalArticle

@article{8050a3ce270a4f119bdbe7b1a04c308f,
title = "Arilvax PowderJect",
author = "Alan Barrett",
year = "2002",
month = "7",
day = "1",
language = "English (US)",
volume = "3",
pages = "992--995",
journal = "Expert Opinion on Investigational Drugs",
issn = "1354-3784",
publisher = "Taylor and Francis Ltd.",
number = "7",

}

TY - JOUR

T1 - Arilvax PowderJect

AU - Barrett, Alan

PY - 2002/7/1

Y1 - 2002/7/1

UR - http://www.scopus.com/inward/record.url?scp=0036667142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036667142&partnerID=8YFLogxK

M3 - Article

C2 - 12186277

AN - SCOPUS:0036667142

VL - 3

SP - 992

EP - 995

JO - Expert Opinion on Investigational Drugs

JF - Expert Opinion on Investigational Drugs

SN - 1354-3784

IS - 7

ER -